ClinConnect ClinConnect Logo
Search / Trial NCT06880952

Effect of Post-operative Chlorhexidine on Postoperative Pain and Complications After Surgical Removal of Mandibular Third Molars

Launched by ISALA · Mar 17, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

Third Molar Chlorhexidine

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • healthy adults (18+) referred by their dentist for third molar removal
  • Exclusion Criteria:
  • active pericoronitis or other infections
  • planned coronectomy
  • trismus
  • chronic pain
  • pregnancy
  • known allergies to local anesthesia

About Isala

Isala is a leading healthcare organization based in the Netherlands, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a strong focus on collaboration and multidisciplinary approaches, Isala integrates clinical expertise and cutting-edge technology to develop and evaluate new treatments across various therapeutic areas. The organization prioritizes patient safety and ethical standards, ensuring that all research initiatives are conducted with the highest level of integrity. Through its dedication to scientific excellence and patient outcomes, Isala strives to contribute significantly to the global medical community.

Locations

Zwolle, Overijssel, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported